SCHEMBL7467638

SCHEMBL7467638

CCCCOC(=O)N1CCC(C#N)(NC(=O)C(CC2CCCCC2)NC(=O)N2CCOCC2)CC1

nearest known ligand 0.73

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CTSS P25774 20/20 0.73
CTSL P07711 5/20 0.73
CTSB P07858 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5361155 0.93 CTSS (0.79) CTSSCTSLCTSB
SCHEMBL6107857 0.87 CTSS (0.80) CTSSCTSL
SCHEMBL6110300 0.86 CTSS (0.87) CTSSCTSLCTSB
SCHEMBL5362667 0.86 CTSS (0.77) CTSSCTSLCTSB
SCHEMBL6107942 0.86 CTSS (0.79) CTSSCTSL
SCHEMBL6104323 0.85 CTSS (0.78) CTSSCTSL
SCHEMBL6109403 0.85 CTSS (0.83) CTSSCTSL
SCHEMBL21067516 0.84 CTSS (1.00) CTSSCTSLCTSB
SCHEMBL6106855 0.84 CTSS (1.00) CTSSCTSLCTSB
SCHEMBL6106998 0.84 CTSS (0.94) CTSSCTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed